Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The timeline depends on how quickly you get the ID in
The Triple-Agonist Revolution Retatrutide is an investigational synthetic peptide that represents the first tri-agonist in metabolic medicine
Safety and Quality: VIOS maintains strict quality and safety standards in producing GLP-1
It is important to note that alopecia is listed as an adverse reaction in the SmPCs of some licensed GLP-1 receptor agonists (for example, semaglutide)
Semaglutide GLP-1 lowers levels of systolic and diastolic blood pressure, improving heart health, which can lend itself to improved weight loss results
The European Medicines Agency (EMA) and NICE have not issued guidance recommending GLP-1 receptor agonists for autoimmune disease management, reflecting the current lack of robust, high-quality evidence from randomised controlled trials
